RedHill Biopharma (RDHL) Net Margin Growth (1y) (2013 - 2023)
RedHill Biopharma (RDHL) Net Margin Growth (1y) (2013 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -2,064.00 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -195.00 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 376.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -303.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -58.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 306.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 328,068.00 |
| Mar 31, 2023 | -31,718.00 |
| Dec 31, 2022 | 10,107.00 |
| Sep 30, 2022 | -18,446.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 3,182.00 |
| Dec 31, 2021 | -69,338.00 |
| Sep 30, 2021 | 1,296.00 |
| Jun 30, 2021 | -4,284.00 |
| Mar 31, 2021 | -149,215.00 |
| Dec 31, 2020 | -69,537.00 |
| Sep 30, 2020 | -68,038.00 |
| Jun 30, 2020 | -86,087.00 |
| Mar 31, 2020 | 106,491.00 |
| Dec 31, 2019 | -16,812.00 |
| Sep 30, 2019 | 30,387.00 |
| Jun 30, 2019 | 90,371.00 |
| Mar 31, 2019 | 8,133.00 |
| Dec 31, 2018 | -291.00 |
| Sep 30, 2018 | -38,975.00 |